new glp-1 medications List of approved and pending GLP-1 Medications for Weight Loss:

Common Side Effects Most side effects are gastrointestinal and typically occur during the titration phase (the first 1620 weeks when your dose is slowly increasing): Very Common: Nausea (affects ~44% of users), diarrhea, vomiting, and constipation

Animal studies have found that vitamin E inhibits stone initiation by reducing calcium oxalate crystallization, inhibiting crystal deposition in kidney tubule cells, and protecting against oxidative injury in kidney cells (Huang 2006

I know that I am lucky to have a supportive doctor who is happy to prescribe me B12 and that others arent so fortunate

Cyp1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies